Nomura Holdings’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.83M Buy
42,700
+26,700
+167% +$4.92M 0.02% 493
2025
Q4
$2.82M Sell
16,000
-9,000
-36% -$1.47M ﹤0.01% 975
2025
Q3
$3.5M Buy
25,000
+19,000
+317% +$2.57M 0.01% 914
2025
Q2
$754K Sell
6,000
-9,000
-60% -$1.12M ﹤0.01% 1054
2025
Q1
$2.05M Buy
15,000
+9,000
+150% +$1.29M ﹤0.01% 1048
2024
Q4
$918K Buy
+6,000
New +$1.01M ﹤0.01% 1512
2022
Q1
Sell
-1,000
Closed -$240K 1994
2021
Q4
$240K Buy
+1,000
New +$257K ﹤0.01% 1771
2018
Q1
Sell
-32,500
Closed -$10.4M 1433
2017
Q4
$10.4M Buy
32,500
+17,500
+117% +$5.61M 0.02% 440
2017
Q3
$4.71M Hold
15,000
0.01% 562
2017
Q2
$4.03M Sell
15,000
-75,000
-83% -$19.8M 0.01% 611
2017
Q1
$24.6M Buy
90,000
+13,000
+17% +$3.68M 0.06% 139
2016
Q4
$22M Buy
77,000
+75,000
+3,750% +$22.2M 0.06% 205
2016
Q3
$620K Hold
2,000
﹤0.01% 860
2016
Q2
$480K Hold
2,000
﹤0.01% 872
2016
Q1
$515K Buy
+2,000
New +$528K ﹤0.01% 870
2015
Q1
Sell
-15,800
Closed -$5.36M 1785
2014
Q4
$5.36M Sell
15,800
-3,000
-16% -$971K 0.01% 568
2014
Q3
$6.2M Buy
18,800
+10,500
+127% +$3.46M 0.02% 612
2014
Q2
$2.66M Buy
8,300
+8,000
+2,667% +$2.41M ﹤0.01% 992
2014
Q1
$94K Buy
+300
New +$95.2K ﹤0.01% 2517

Other funds holding BIIB

Nomura Holdings's BIIB Position: Q1 2026 in Review

Nomura Holdings reduced its Biogen (BIIB) stake by 89% in Q1 2026, selling an estimated $24.1M and leaving 16,730 shares worth $3.07M. The position accounts for 0.01% of the portfolio, ranked #793.

Nomura Holdings first reported a position in BIIB in Q2 2013 and has held it in 47 quarters since. The position peaked at $49.5M in Q3 2019. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Nomura Holdings held 16,730 shares of Biogen worth $3.07M as of Q1 2026.
  • Nomura Holdings sold 130,531 Biogen shares in Q1 2026, an estimated $24.1M.
  • Biogen made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #793 holding.
  • Nomura Holdings first reported a position in Biogen in Q2 2013 and has held it in 47 quarters since.
  • Nomura Holdings's Biogen position peaked at $49.5M in Q3 2019.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.